Ignite Creation Date:
2025-12-24 @ 9:24 PM
Ignite Modification Date:
2026-05-24 @ 7:43 AM
Study NCT ID:
NCT00775632
Status:
COMPLETED
Last Update Posted:
2016-06-23
First Post:
2008-10-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Alemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell Transplants
Sponsor:
University Health Network, Toronto
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
UHN REB 07-0436C
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |